Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;28(7):2340-2349.
doi: 10.1007/s10461-024-04332-z. Epub 2024 May 14.

Identifying Best Practices for Increasing HIV Pre-exposure Prophylaxis (PrEP) Use and Persistence in the United States: A Systematic Review

Affiliations

Identifying Best Practices for Increasing HIV Pre-exposure Prophylaxis (PrEP) Use and Persistence in the United States: A Systematic Review

Emiko Kamitani et al. AIDS Behav. 2024 Jul.

Abstract

A qualitative systematic review was conducted to evaluate pre-exposure prophylaxis (PrEP) interventions, describe characteristics of best practices for increasing PrEP use and persistence, and explore research gaps based on current PrEP interventions. We searched CDC's Prevention Research Synthesis (PRS) Project's cumulative HIV database (includes CINAHL, EMBASE, Global Health, MEDLINE, PsycInfo, and Sociological Abstracts) to identify PrEP intervention studies conducted in the U.S., published between 2000 and 2022 (last searched January 2023). Eligibility criteria include studies that evaluated PrEP interventions for persons testing negative for HIV infection, or for healthcare providers who prescribed PrEP; included comparisons between groups or pre/post; and reported at least one relevant PrEP outcome. Each eligible intervention was evaluated on the quality of study design, implementation, analysis, and strength of evidence (PROSPERO registration number: CRD42021256460). Of the 26 eligible interventions, the majority were focused on men who have sex with men (n = 18) and reported PrEP adherence outcomes (n = 12). Nine interventions met the criteria for Best Practices (i.e., evidence-based interventions, evidence-informed interventions). Five were digital health interventions while two implemented individual counseling, one offered motivational interviewing, and one provided integrated medical care with a PrEP peer navigator. Longer intervention periods may provide more time for intervention exposure to facilitate behavioral change, and engaging the community when developing, designing and implementing interventions may be key for effectiveness. For digital health interventions, two-way messaging may help participants feel supported. Research gaps included a lack of Best Practices for several populations (e.g., Black persons, Hispanic/Latino persons, persons who inject drugs, and women of color) and evidence for various intervention strategies (e.g., interventions for promoting provider's PrEP prescription behavior, peer support). These findings call for more collaborative work with communities to develop interventions that work and implement and disseminate Best Practices for increasing PrEP use and persistence in communities.

Keywords: Evidence-based practice; HIV; Interventions; PrEP persistence; PrEP user; Pre-exposure prophylaxis; Systematic review.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Flow diagram of evidence-based and evidence-informed interventions

References

    1. U.S. Centers for Disease Control and Prevention. PrEP Effectiveness. 2021; https://www.cdc.gov/hiv/basics/prep/prep-effectiveness.html. Accessed August 27, 2021.
    1. HIV.gov. What is Ending the HIV Epidemic in the U.S.? 2019; https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/overview. Accessed February 3, 2022.
    1. U.S. Department of Health and Human Services. HIV National Strategic Plan for the United States: A Roadmap to End the Epidemic 2021–2021. 2021. https://files.hiv.gov/s3fs-public/HIV-National-Strategic-Plan-2021-2025.....
    1. U.S. Food and Drug Administration. Truvada for PrEP Fact Sheet: Ensuring Safe and Proper Use. 2012; https://www.fda.gov/media/83586/download.
    1. Centers for Disease Control and Prevention. HIV Surveillance Report, 2021. 2023;34. https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-34/index.html. Accessed May 24, 2023.

Publication types

Substances